Target intelligence / Profile preview

Streptavidin (None)

Target
None
Molecular classification
Biotin-binding protein, Bacterial protein, Homotetrameric protein
01

Overview

Streptavidin is a 52-55 kDa homotetrameric protein purified from the bacterium *Streptomyces avidinii* that exhibits extraordinarily high affinity for biotin (vitamin B7 or H)[1][2]. With a dissociation constant on the order of 10^-14^ to 10^-15^ M, the streptavidin-biotin interaction represents one of the strongest non-covalent bonds known in nature[1][2]. **Structural characteristics**: The protein consists of four identical subunits, each composed of 159 amino acid residues in the full-length form, though it is commonly proteolytically processed to a "core" form of 125-139 residues[1][2]. Each monomer adopts an eight-stranded antiparallel β-barrel tertiary structure with a biotin-binding site located at one end of each barrel[1][3][4]. The tetrameric quaternary structure can be considered a dimer of functional dimers, with each subunit contributing critical residues (particularly Trp120) to the binding site of neighboring subunits[1][3][4]. **Binding mechanism**: The exceptional binding affinity originates from multiple factors including high shape complementarity between the binding pocket and biotin, an extensive hydrogen bonding network involving eight first-shell residues (Asn23, Tyr43, Ser27, Ser45, Asn49, Ser88, Thr90, and Asp128), numerous van der Waals interactions within the hydrophobic binding pocket lined with tryptophan residues, and stabilization of a flexible loop (L3/4, residues 45-52) that closes over bound biotin like a lid, contributing to extremely slow dissociation rates[1][3][4]. **Stability**: The streptavidin-biotin complex exhibits remarkable resistance to organic solvents, denaturants (such as guanidinium chloride), detergents (including SDS and Triton X-100), proteolytic enzymes, and extremes of temperature and pH[1]. The protein itself is stable over a wide pH range and requires up to 20 minutes at 100°C in 0.2% SDS to dissociate the tetrameric structure[2]. **Comparison to avidin**: While streptavidin shares identical biotin-binding properties with avidin (a related protein from egg white), it lacks the glycoprotein portion and has only 30% sequence homology with avidin[2]. Streptavidin's near-neutral isoelectric point (pI 5-6 versus 10 for avidin) results in lower non-specific binding in most biological applications[2]. **Applications**: Streptavidin is extensively used in molecular biology, bionanotechnology, diagnostics, and research applications including immunoassays, protein purification, detection systems, and biosensors, where its strong biotin-binding capability serves as a versatile molecular tool rather than as a therapeutic target[1][2].

Other names
Core streptavidin
02

Mechanism of action

Not applicable

03

Biological functions

Biotin bindingPossible microbial defense mechanism
04

Disease associations

None
05

Safety considerations

Not applicable for therapeutic useChemical labeling with fluorophores can impair biotin-binding affinityNon-specific binding can occur, though typically lower than avidin due to near-neutral isoelectric point (pI 5-6)
06

Interacting drugs

None
07

Biomarkers

Not applicable

Beyond the preview

Go deeper on Streptavidin (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Streptavidin (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call